Bivalent ligands as specific pharmacological tools for G protein-coupled receptor dimers
- PMID:19075611
- DOI: 10.2174/157016308786733591
Bivalent ligands as specific pharmacological tools for G protein-coupled receptor dimers
Abstract
G protein-coupled receptors (GPCRs) are major drug targets and are organized in dimeric/oligomeric complexes. These dimers may be composed of identical (homodimer) or different (heterodimer) receptors. GPCR dimerization provides new opportunities for drug design. Different strategies have been developed to specifically target GPCR dimers. Bivalent ligands, which are composed of two functional pharmacophores linked by a spacer, are among the most promising strategies. Due to the constitutive nature of GPCR dimers, bivalent ligands are expected in most cases to bind to and stabilize preexisting dimers rather then to promote ligand-induced dimerization. Most studies on GPCR dimerization were conducted so far in heterologous expression systems. Due the development of heterodimer-specific tools such as bivalent ligands, dimerization has now been confirmed for an increasing number of receptors in native tissues. In this review, we will discuss general considerations for the design and synthesis of bivalent ligands and present the functional in vitro and in vivo properties of reported bivalent ligands.
Similar articles
- Design of bivalent ligands targeting putative GPCR dimers.Huang B, St Onge CM, Ma H, Zhang Y.Huang B, et al.Drug Discov Today. 2021 Jan;26(1):189-199. doi: 10.1016/j.drudis.2020.10.006. Epub 2020 Oct 16.Drug Discov Today. 2021.PMID:33075471Free PMC article.Review.
- Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them?Carli M, Kolachalam S, Aringhieri S, Rossi M, Giovannini L, Maggio R, Scarselli M.Carli M, et al.Curr Neuropharmacol. 2018 Jan 30;16(2):222-230. doi: 10.2174/1570159X15666170518151127.Curr Neuropharmacol. 2018.PMID:28521704Free PMC article.Review.
- Study of G protein-coupled receptors dimerization: From bivalent ligands to drug-like small molecules.Qian M, Sun Z, Chen X, Van Calenbergh S.Qian M, et al.Bioorg Chem. 2023 Nov;140:106809. doi: 10.1016/j.bioorg.2023.106809. Epub 2023 Aug 26.Bioorg Chem. 2023.PMID:37651896Review.
- Physiological relevance of GPCR oligomerization and its impact on drug discovery.Panetta R, Greenwood MT.Panetta R, et al.Drug Discov Today. 2008 Dec;13(23-24):1059-66. doi: 10.1016/j.drudis.2008.09.002. Epub 2008 Oct 14.Drug Discov Today. 2008.PMID:18824244Review.
- Developing a Biased Unmatched Bivalent Ligand (BUmBL) Design Strategy to Target the GPCR Homodimer Allosteric Signaling (cAMP over β-Arrestin 2 Recruitment) Within the Melanocortin Receptors.Lensing CJ, Freeman KT, Schnell SM, Speth RC, Zarth AT, Haskell-Luevano C.Lensing CJ, et al.J Med Chem. 2019 Jan 10;62(1):144-158. doi: 10.1021/acs.jmedchem.8b00238. Epub 2018 May 9.J Med Chem. 2019.PMID:29669202Free PMC article.
Cited by
- From the Catastrophic Objective Irreproducibility of Cancer Research and Unavoidable Failures of Molecular Targeted Therapies to the Sparkling Hope of Supramolecular Targeted Strategies.Alekseenko I, Kondratyeva L, Chernov I, Sverdlov E.Alekseenko I, et al.Int J Mol Sci. 2023 Feb 1;24(3):2796. doi: 10.3390/ijms24032796.Int J Mol Sci. 2023.PMID:36769134Free PMC article.Review.
- Receptor-Receptor Interactions as a Widespread Phenomenon: Novel Targets for Drug Development?Guidolin D, Marcoli M, Tortorella C, Maura G, Agnati LF.Guidolin D, et al.Front Endocrinol (Lausanne). 2019 Feb 18;10:53. doi: 10.3389/fendo.2019.00053. eCollection 2019.Front Endocrinol (Lausanne). 2019.PMID:30833931Free PMC article.Review.
- Design of bivalent ligands targeting putative GPCR dimers.Huang B, St Onge CM, Ma H, Zhang Y.Huang B, et al.Drug Discov Today. 2021 Jan;26(1):189-199. doi: 10.1016/j.drudis.2020.10.006. Epub 2020 Oct 16.Drug Discov Today. 2021.PMID:33075471Free PMC article.Review.
- Heterodimerization of Dibenzodiazepinone-Type Muscarinic Acetylcholine Receptor Ligands Leads to Increased M2R Affinity and Selectivity.She X, Pegoli A, Mayr J, Hübner H, Bernhardt G, Gmeiner P, Keller M.She X, et al.ACS Omega. 2017 Oct 31;2(10):6741-6754. doi: 10.1021/acsomega.7b01085. Epub 2017 Oct 16.ACS Omega. 2017.PMID:30023530Free PMC article.
- Reinterpreting anomalous competitive binding experiments within G protein-coupled receptor homodimers using a dimer receptor model.Casadó-Anguera V, Moreno E, Mallol J, Ferré S, Canela EI, Cortés A, Casadó V.Casadó-Anguera V, et al.Pharmacol Res. 2019 Jan;139:337-347. doi: 10.1016/j.phrs.2018.11.032. Epub 2018 Nov 22.Pharmacol Res. 2019.PMID:30472462Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources